Floatz logo

Valaciclovir

Herpes Simplex

Hugo LovheimSmall moleculePhase 4 / ApprovedDormant
BBB
74/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
60/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Herpes Simplex cohort.

Asset / SponsorPhaseRating
aciclovir
National Center for Research Resources (NCRR)
Phase 3BBB

Same molecule, other indications

Valaciclovir is also rated in:

schizoaffective disorderDormant
BB
Indicative ·
68 / 100
View asset →
non-small cell lung carcinomaDormant
BB
Indicative ·
66 / 100
View asset →
glioblastomaDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →